Galectin Therapeutics (GALT) Dividends payables (2010 - 2026)

Galectin Therapeutics' Dividends payables history runs 16 years deep, the most recent figure standing at $63000.0 for Q4 2025.

• In Q4 2025, Dividends payables changed 0.0% year-over-year to $63000.0; the TTM figure through Dec 2025 stood at $63000.0 (changed 0.0% YoY), while the FY2025 annual figure was $63000.0, changed 0.0% from the prior year.
• Dividends payables for Q4 2025 stood at $63000.0, roughly flat from $63000.0 in the prior quarter.
• The five-year high for Dividends payables was $65000.0 in Q2 2021, with the low at $63000.0 in Q4 2023.
• The 5-year median for Dividends payables is $63500.0 (2022), against an average of $63700.0.
• The sharpest annual moves came in 2021 and 2023: Dividends payables changed 0.0% in 2021, then slipped 1.56% in 2023.
• Galectin Therapeutics' Dividends payables stood at $65000.0 in 2021, then declined by 1.54% to $64000.0 in 2022, then retreated by 1.56% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025.
• Business Quant data shows GALT's Dividends payables at $63000.0 in Q4 2025, $63000.0 in Q2 2025, and $63000.0 in Q4 2024.